16 participants
Ruxolitinib in Operable Head and Neck Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-10-30
- Start Date:
- 2018-06-08
- Completion:
- 2023-10-18
Conditions
- Head and Neck Squamous Cell Carcinoma
Interventions
- DRUG